Riskpilot← Back to searchSign inGet full accessDan-Inject ApS
APSActiveCVR 39736497Olgas Alle 4Wholesale of other machinery and equipment · NACE 4664Est. 20189 employees
Revenue 2024
DKK 6,7M
-21% vs 2023
EBITDA margin
31.1%
-51% vs 2023
Equity ratio
29.7%
Financial strength
Net profit 2024
DKK 69K
-96% vs 2023
| Revenue | DKK 6,7M | -21% |
| EBITDA | DKK 2,1M | -51% |
| Net profit | DKK 69K | -96% |
| Total assets | DKK 18,2M | -7% |
| Equity | DKK 5,4M | +1% |
| Employees | 9 | — |
Legal name
Dan-Inject ApS
CVR number
39736497
Legal form
Anpartsselskab
NACE code
4664 · Wholesale of other machinery and equipment
Founded
20. juli 2018
Share capital
DKK 201.000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren i forening med et bestyrelsesmedlem.
Company purpose
Selskabets formål er produktion og salg af veterinærudstyr samt anden virksomhed, der efter bestyrelsens skøn står i forbindelse hermed.
Address
Olgas Alle 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 4.473 | 6.315 | 7.175 | 7.351 | 8.543 | 6.711 |
| Staff expenses | -3.390 | -3.245 | -3.925 | -3.656 | -4.286 | -4.623 |
| EBITDA | 1.083 | 3.070 | 3.250 | 3.695 | 4.257 | 2.088 |
| Depreciation & amort. | -1.244 | -1.270 | -1.270 | -1.276 | -1.295 | -1.310 |
| EBIT | -161 | 1.799 | 1.980 | 2.419 | 2.962 | 778 |
| Net financials | -897 | -796 | -647 | -538 | -706 | -688 |
| Profit before tax | -1.058 | 1.003 | 1.332 | 1.881 | 2.256 | 90 |
| Tax | -232 | 221 | 294 | 415 | 498 | 21 |
| Net profit | -825 | 782 | 1.038 | 1.466 | 1.758 | 69 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 20.933 | 19.058 | 18.647 | 19.090 | 19.566 | 18.158 |
| Equity | 726 | 1.508 | 2.546 | 3.563 | 5.321 | 5.390 |
| Long-term debt | 14.749 | 12.650 | 8.850 | 6.450 | 4.650 | 4.000 |
| Short-term debt | 5.459 | 4.901 | 6.968 | 8.379 | 8.400 | 7.551 |
| Total debt | 20.208 | 17.551 | 15.818 | 14.829 | 13.050 | 11.551 |
EBITDA margin
31.1%
This company
15.8%
Market median
+97% vs market
20192024
Equity ratio
29.7%
This company
38.2%
Market median
-22% vs market
20192024
Return on equity
1.3%
This company
18.4%
Market median
-93% vs market
20192024
Net profit margin
1.0%
This company
8.1%
Market median
-88% vs market
20192024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20192024
Debt / equity
2.37×
This company
0.62×
Market median
-282% vs market
20192024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2018-07-20 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SS Management | Management | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
RAVN JENSEN HOLDING A/S | Company | 33.3% | 33.3% | 2018 |
Saga Holding ApS | Company | 33.3% | 33.3% | 2018 |
Saathi Holding ApS | Company | 33.3% | 33.3% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
RAVN JENSEN HOLDING A/S
Dan-Inject ApS Board members of Dan-Inject ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Steffen Stræde | Management | 0 companies |
| Søren Ravn Jensen | Board of Directors | 0 companies |
| Jesper Stagegaard | Board of Directors | 0 companies |